289 related articles for article (PubMed ID: 18175165)
1. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
[TBL] [Abstract][Full Text] [Related]
2. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis.
Frich L; Hagen G; Brabrand K; Edwin B; Mathisen O; Aaløkken TM; Gladhaug IP
J Vasc Interv Radiol; 2007 Sep; 18(9):1134-40. PubMed ID: 17804776
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
4. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
5. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
7. Semiautomated versus manual evaluation of liver metastases treated by radiofrequency ablation.
Keil S; Bruners P; Ohnsorge L; Plumhans C; Behrendt FF; Stanzel S; Sühling M; Günther RW; Das M; Mahnken AH
J Vasc Interv Radiol; 2010 Feb; 21(2):245-51. PubMed ID: 20123208
[TBL] [Abstract][Full Text] [Related]
8. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
[TBL] [Abstract][Full Text] [Related]
10. Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver?
Ringe KI; Wacker F; Raatschen HJ
Acta Radiol; 2015 Jan; 56(1):10-7. PubMed ID: 24445091
[TBL] [Abstract][Full Text] [Related]
11. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
[TBL] [Abstract][Full Text] [Related]
12. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
[TBL] [Abstract][Full Text] [Related]
13. Oblique approach for CT-guided liver radiofrequency ablation using multiplanar reformation images in hepatocellular carcinoma.
Kamei S; Matsuda J; Hagihara M; Kitagawa A; Izumi Y; Katsuda E; Oshima Y; Ikeda S; Kimura J; Ota T; Kawamura T; Ishiguchi T
Jpn J Radiol; 2012 Jul; 30(6):533-9. PubMed ID: 22528338
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of CT findings after radiofrequency ablation of hepatic tumors.
Park MH; Rhim H; Kim YS; Choi D; Lim HK; Lee WJ
Radiographics; 2008; 28(2):379-90; discussion 390-2. PubMed ID: 18349446
[TBL] [Abstract][Full Text] [Related]
15. Immediate Postablation
Cornelis FH; Petre EN; Vakiani E; Klimstra D; Durack JC; Gonen M; Osborne J; Solomon SB; Sofocleous CT
J Nucl Med; 2018 Sep; 59(9):1360-1365. PubMed ID: 29439012
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
Vandenbroucke F; Vandemeulebroucke J; Ilsen B; Verdries D; Belsack D; Everaert H; Buls N; Ros PR; de Mey J
J Vasc Interv Radiol; 2014 Aug; 25(8):1240-9. PubMed ID: 24954606
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
[TBL] [Abstract][Full Text] [Related]
18. Assessment of liver ablation using cone beam computed tomography.
Abdel-Rehim M; Ronot M; Sibert A; Vilgrain V
World J Gastroenterol; 2015 Jan; 21(2):517-24. PubMed ID: 25593467
[TBL] [Abstract][Full Text] [Related]
19. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases.
Minami Y; Minami T; Chishina H; Kono M; Arizumi T; Takita M; Yada N; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
Dig Dis; 2016; 34(6):687-691. PubMed ID: 27750238
[TBL] [Abstract][Full Text] [Related]
20. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
